Corgentech, Inc.
Press releases archived for reference only.
650 Gateway Boulevard
South San Francisco
California
94080
United States
About Corgentech, Inc.
42 articles about Corgentech, Inc.
-
Corgentech, Inc. Changes Name To Anesiva To Reflect Focus On Robust Pipeline Of Pain Therapeutics
6/22/2006
-
Corgentech, Inc. Secures $30 Million Committed Equity Financing Facility
6/20/2006
-
Corgentech, Inc. Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries; Shares Up
6/14/2006
-
Corgentech, Inc. To Present At Pacific Growth Equities Life Sciences Growth Conference And Needham & Company Fifth Annual Biotechnology And Medical Technology Conference
6/7/2006
-
Corgentech, Inc. Announces Appointment Of K. Peony Yu As Vice President, Clinical Research And Michael Leong As Director, Clinical Research
6/6/2006
-
Corgentech, Inc. Announces Appointment Of Susan Kramer As Vice President Of Preclinical Development
5/30/2006
-
Corgentech, Inc. To Host Webcast Conference Call On Wednesday, May 24, 2006
5/22/2006
-
Corgentech, Inc. Announces Scientific Presentation Of Pivotal Phase 3 Data Demonstrating Significant Pain Reduction Associated With Fast-Acting, Needlefree Local Anesthetic In Children
5/18/2006
-
Corgentech, Inc. Announces First Quarter 2006 Financial Results
5/5/2006
-
Corgentech, Inc. Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief Of Pain And Improved Function In Elbow Tendonitis
5/4/2006
-
Corgentech, Inc. Announces Presentation Of 3268 Phase 3 Data At 2006 Pediatric Academic Societies' Annual Meeting
4/28/2006
-
Corgentech, Inc. To Announce First Quarter 2006 Financial Results And Host Webcast Conference Call On May 4, 2006
4/27/2006
-
Corgentech, Inc. Files $100 Million Mixed Shelf Offering
4/18/2006
-
The Day In Review: Sanofi-Aventis (France) Adds To Generics Business
3/26/2006
-
Corgentech, Inc. To Present At CIBC World Markets' Annual Biotechnology And Specialty Pharmaceuticals Conference 2006
3/26/2006
-
Corgentech, Inc. Says Pain Drug, 4975 For Hernia Repair Pain Fails In Mid-Stage Study
3/26/2006
-
The Day In Review: Vertex Pharmaceuticals Incorporated Reports Positive Arthritis Drug News
3/9/2006
-
Corgentech, Inc. Phase 2 Trial Of ALGRX 4975 Meets Primary Endpoint Of Decreased Pain For Tendonitis Patients
3/9/2006
-
Corgentech, Inc. Presents Clinical Data From Phase 1/2 Trial Of Avrina(TM), Drug Candidate For Eczema
3/6/2006
-
Corgentech, Inc. To Webcast Presentation From Lehman Brothers 2006 Global Healthcare Conference
3/3/2006